ComplianceOnline

Strategies on how to Minimize the Rise of Enrollment Violations in Clinical Trials

  • By: Kimberly Kiner, BSc. CCRA
  • Date: February 16, 2010
Webinar All Access Pass Subscription Abstract:

This article will discuss the increasing trend of protocol enrollment violations, how enrollment violations produces detrimental effects on premarket clinical trials, and how sponsors/CROs, sites and CRAs can help minimize future violations in an effort to increase subject safety and data integrity.

Bookmark and Share

Compliance Trainings

Risk Based Monitoring for GCP Compliance
By - Laura Brown
On Demand Access Anytime

Compliance Standards

Best Sellers
You Recently Viewed
    Loading